← All indications
Iridocyclitis
Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.
Drugs by status
Approved for this indication (3)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (14)
- Sirion Therapeutics
- Alcon
- Aldeyra Therapeutics, Inc.
- Allergan
- Eyegate Pharmaceuticals, Inc.
- Lux Biosciences, Inc.
- Chulalongkorn University
- University of California, San Francisco
- Virginia Eye Consultants
- National Taiwan University
- KhonKaen University
- Hokkaido University
- Assistance Publique - Hôpitaux de Paris
- Hwang Pacific Foundation
Organization Involved with Phase 2 Indications (8)
Organization Involved with Other Experimental Indications (2)